Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Invested Capital | Net Income Common Stock | Return on Invested Capital |
---|---|---|---|
6/30/2025 | $ 108.74M | $ -74.18M | -68.22% |
3/31/2025 | $ 124.32M | $ -53.26M | -42.84% |
12/31/2024 | $ -20.6M | $ -131.21M | 0% |
9/30/2024 | $ 59.23M | $ -76.95M | -129.92% |
6/30/2024 | $ 77.07M | $ -75.73M | -98.27% |
3/31/2024 | $ 70.28M | $ -99.59M | -141.7% |
12/31/2023 | $ 103.22M | $ -87.68M | -84.95% |
9/30/2023 | $ 66.59M | $ -81.67M | -122.65% |
6/30/2023 | $ 82.05M | $ -82.25M | -100.25% |
3/31/2023 | $ 96.72M | $ -83.39M | -86.22% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for ALIGOS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Inv. Capital [ $ -123.32M ]
(=) ROIC [ 0% ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.36K |
---|---|
min | -46.36% |
max | 48.66% |
average | 0.68% |
median | 3.38% |
std | 15.2% |